The pharmaceutical industry stands on the brink of a radical transformation, driven by the growing integration of artificial intelligence (AI) in drug development. This evolution is marked by strategic collaborations, significant technological advancements, and massive investments. Sanofi, a major player in the sector, exemplifies this trend with its partnership with OpenAI to accelerate drug discovery. Meanwhile, Takeda is revolutionizing psoriasis treatment with the launch of the first AI-designed drug, illustrating a major breakthrough in pharmaceutical research.
Débloquez l'Analyse Complète
Accédez instantanément à nos insights exclusifs générés par IA, basés sur l'agrégation de centaines de sources sectorielles.
